Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [11] Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease
    Shi, G-M
    Xu, Q.
    Zhu, C-Y
    Yang, Y-L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (02) : 576 - 582
  • [12] Determination of administered activities for the treatment of Graves' disease with iodine-131: Proposition of a simplified dosimetric procedure
    Soli, Idrissa Adamou
    Issoufou, Djibrillou Moussa
    Rahabi, Skander
    Ali, Ada
    Adehossi, Eric
    Bouyoucef, Salah Eddine
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2021, 20 (03) : 222 - 227
  • [13] Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131
    Traisk, Frank
    Tallstedt, Leif
    Abraham-Nordling, Mirna
    Andersson, Tommy
    Berg, Gertrud
    Calissendorff, Jan
    Hallengren, Bengt
    Hedner, Pavo
    Lantz, Mikael
    Nystrom, Ernst
    Ponjavic, Vesna
    Taube, Adam
    Torring, Ove
    Wallin, Goran
    Asman, Peter
    Lundell, Goran
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10): : 3700 - 3707
  • [14] Predictive factors of peak radioactive iodine uptake moving forward in Graves' disease patients receiving iodine-131 therapy
    Zhang, R.
    Qin, L.
    Wang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S535 - S535
  • [15] Editorial: How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?
    Kalinyak, JE
    McDougall, IR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03): : 975 - 977
  • [16] Measurement of the radioactive body burden in patients receiving iodine-131 treatment for carcinoma of the thyroid
    Ravichandran, R
    Supe, SS
    Jayasree, U
    Devaru, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (04) : 464 - 464
  • [17] Measurement of the radioactive body burden in patients receiving Iodine-131 treatment for carcinoma of the thyroid
    R. Ravichandran
    S. S. Supe
    U. Jayasree
    S. Devaru
    European Journal of Nuclear Medicine, 1997, 24 : 464 - 464
  • [18] The outcome of patients with relapsed or refractory Graves' disease and hyperfunctioning uni- or multinodular goiter after a personalized dose of Iodine-131
    Florimonte, L.
    Butti, I.
    Pagani, L.
    Di Leo, C.
    Maffioli, L. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S334 - S334
  • [19] Body composition changes in patients with differentiated thyroid cancer after iodine-131 treatment and short-term levothyroxine replacement and suppression therapy
    Wang, Ru
    Qin, Shanshan
    Qiao, Tingting
    Jiang, Wen
    Tong, Junyu
    Lu, Ganghua
    Gao, Dingwei
    Zhang, Mengyu
    Lv, Zhongwei
    Li, Dan
    Chai, Li
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (02): : 257 - 265
  • [20] STUDIES ON TREATMENT OF HYPERTHYROIDISM WITH IODINE-131
    TORIZUKA, K
    MORI, T
    KONISHI, J
    MORITA, R
    HAMAMOTO, K
    KUSKAABE, T
    MIYAKE, T
    FUKASE, M
    JOURNAL OF NUCLEAR MEDICINE, 1967, 8 (05) : 335 - &